Use of digoxin immune Fab for the regulation of sodium/potassium ATPase activity in preeclamptic and eclamptic patients

Details for Australian Patent Application No. 2003254159 (hide)

Owner Adair, C.

Inventors Adair, Charles David

Agent Spruson & Ferguson

Pub. Number AU-B-2003254159

PCT Number PCT/US03/23235

PCT Pub. Number WO2004/011028

Priority 10/292,338 12.11.02 US; 10/202,957 25.07.02 US

Filing date 24 July 2003

Wipo publication date 16 February 2004

Acceptance publication date 24 September 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 39/00 (2006.01) General protective or antinoxious agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 10/292,338 12.11.02 US; 10/202,957 25.07.02 US

25 March 2004 Application Open to Public Inspection

  Published as AU-B-2003254159

24 September 2009 Application Accepted

  Published as AU-B-2003254159

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003254160-METHOD OF CURING AN ANISOTROPIC CONDUCTIVE COMPOUND

2003254158-NUCLEOSIDE COMPOUNDS AND THEIR USE FOR TREATING CANCER AND DISEASES ASSOCIATED WITH SOMATIC MUTATIONS